hCG, the centerpiece of life and death

International Journal of Endocrinology and Metabolism

Volumn 9, Issue 2, 2011, Pages 335-352

  Cole, Laurence A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Choriocarcinoma; Cytotrophoblast; Human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CHORIONIC GONADOTROPIN VACCINE; LUTEINIZING HORMONE RECEPTOR; PROTEIN VARIANT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CELL INVASION; COLORECTAL CANCER; HORMONE ACTION; HUMAN; HUMAN DEVELOPMENT; NONHUMAN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SULFATION; TUMOR PROMOTION;

EID: 84857334346     PISSN: 1726913X     EISSN: 17269148     Source Type: Journal    
DOI: 10.5812/kowsar.1726913x.3398     Document Type: Article

References (169)

1. Aschner B. About the functioning the pituitary. pflug Arch Eur J Phy. 1912;146(1):1-146.
2. Hirose T. Experimentalle histologische studie zur genese corpus luteum. Mitt Med Fakultd. 1919(23):63-70.
3. Aschheim S, Zondek B. The hormone of the anterior pituitary: test for detection of the object-hormone. Klin Wochenschr. 1927;6:248-52.
4. Acevedo HF, Hartsock RJ. Metastatic phenotype correlates with high expression of membrane-associated complete beta-human chorionic gonadotropin in vivo. Cancer. 1996;78(11):2388-99.
5. Amr S, Rosa C, Wehmann R, Birken S, Nisula B. Unusual molecular forms of hCG in gestational trophoblastic neoplasia. Ann Endocrinol (Paris). 1984;45(4-5):321-6.
6. Aono T, Goldstein DP, Taymor ML, Dolch K. A radioimmunoassay method for human pituitary luteinizing hormone (LH) and human chorionic gonadotropic (HCG) using 125-I-labeled LH. Am J Obstet Gynecol. 1967;98(7):996-1001.
7. Ascoli M, Segaloff DL. On the structure of the luteinizing hormone/chorionic gonadotropin receptor. Endocr Rev. 1989;10(1):27-44.
8. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem. 2003;49(1):144-54.
9. Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology. 1996;137(4):1402-11.
10. Blithe DL, Nisula BC. Variations in the oligosaccharides on free and combined alpha-subunits of human choriogonadotropin in pregnancy. Endocrinology. 1985;117(5):2218-28.
11. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7(9):623-30.
12. Boorstein WR, Vamvakopoulos NC, Fiddes JC. Human chorionic gonadotropin [beta]-subunit is encoded by at least eight genes arranged in tandem and inverted pairs. Nature. [10.1038/300419a0]. 1982;300(5891):419-22.
13. Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer. 2000;82(9):1553-6.
14. Cole LA. The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma HCG. J Clin Endocrinol Metab. 1987;65(4):811-3.
15. Cole LA, Butler S. HyperglycosylatedhCG, hCGß and HyperglycosylatedhCGß: Interchangeable Cancer Promoters. Mol Cell Endocrinol 2011.
16. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102(2):145-50.
17. Cole LA, Hartle RJ, Laferla JJ, Ruddon RW. Detection of the free beta subunit of human chorionic gonadotropin (HCG) in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma. Endocrinology. 1983;113(3):1176-8.
18. Cole LA, Khanlian SA, Kohorn EI. Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma. J Reprod Med. 2008;53(8):549-57.
19. Fiddes JC, Goodman HM. The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region. Nature. 1980;286(5774):684-7.
20. Fiddes JC, Goodman HM. The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18.
21. Franchimont P, Reuter A, Gaspard U. Ectopic production of human chorionic gonadotropin and its alpha- and beta-subunits. Curr Top Exp Endocrinol. 1978;3:201-16.
22. Hussa R, En H. A two-site immunometric assay in evaluation of low levels of serum hCG. Am Clin Prod Rev. 1984;3(12):12-7.
23. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature. 1994;369(6480):455-61.
24. Lei ZM, Reshef E, Rao V. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab. 1992;75(2):651-9.
25. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science. 1989;245(4917):494-9.
26. Mizuochi T, Nishimura R, Derappe C, Taniguchi T, Hamamoto T, Mochizuki M, et al. Structures of the asparagine-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma. Appearance of triantennary sugar chains and unique biantennary sugar chains. J Biol Chem. 1983;258(23):14126-9.
27. Morgan FJ, Birken S, Canfield R. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem. 1975;250(13):5247.
28. Nishimura R, Ide K, Utsunomiya T, Kitajima T, Yuki Y, Mochizuki M. Fragmentation of the beta-subunit of human chorionic gonadotropin produced by choriocarcinoma. Endocrinology. 1988;123(1):420-5.
29. Policastro PF, Daniels-McQueen S, Carle G, Boime I. A map of the hCG beta-LH beta gene cluster. J Biol Chem. 1986;261(13):5907-16.
30. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn. 1998;18(12):1232-40.
31. Odell W, Griffin J. Pulsatile secretion of human chorionic gonad otropin in normal adults. New Engl J Med. 1987;317(27):1688-91.
32. Swaminathan N, Bahl OP. Dissociation and recombination of the subunits of human chorionic gonadotropin. Biochem Biophys Res Commun. 1970;40(2):422-7.
33. Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972;113(6):751-8.
34. Wehmann RE, Nisula BC. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest. 1981;68(1):184-94.
35. Wide L, Gemzell CA. An immunological pregnancy test. Acta Endocrinol (Copenh). 1960;35:261-7.
36. Zondek B, Aschheim S. The zondek-ascheim pregnancy test. Can Med Assoc J. 1930;22:251-3.
37. Cole LA, Khanlian SA, Riley JM, Butler SA. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med. 2006;51(11):919-29.
38. Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy M, Muller F, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95(10):E240.
39. Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. Endocrinology. 2007;148(10):5011-9.
40. Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008;89(6):1781-6.
41. Schmitt EJ, Barros CM, Fields PA, Fields MJ, Diaz T, Kluge JM, et al. A cellular and endocrine characterization of the original and induced corpus luteum after administration of a gonadotropinreleasing hormone agonist or human chorionic gonadotropin on day five of the estrous cycle. J Anim Sci. 1996;74(8):1915-29.
42. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine. 1997;7(1):15-32.
43. Valmu L, Alfthan H, Hotakainen K, Birken S, Stenman UH. Sitespecific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry. Glycobiology. 2006;16(12):1207-18.
44. Sutton JM. Charge variants in serum and urine hCG. Clin Chim Acta. 2004;341(1-2):199-203.
45. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, et al. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology. 1991;129(3):1559-67.
46. Cole LA, Kardana A, Park SY, Braunstein GD. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab. 1993;76(3):704-10.
47. Kardana A, Cole LA. Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum. J Clin Endocrinol Metab. 1994;79(3):761-7.
48. Nisula BC, Blithe DL, Akar A, Lefort G, Wehmann RE. Metabolic fate of human choriogonadotropin. J Steroid Biochem. 1989;33(4B):733-7.
49. Veldhuis JD, Fraioli F, Rogol AD, Dufau ML. Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest. 1986;77(4):1122-8.
50. Cole LA, DuToit S, Higgins TN. Total hCG tests. Clin Chim Acta. 2011;412(23-24):2216-22.
51. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem. 2004;50(5):874-82.
52. Cole LA. hCG, five independent molecules. Clin Chim Acta. 2011.
53. Cole LA. Individual deviations in human chorionic gonadotropin concentrations during pregnancy. Am J Obstet Gynecol. 2011;204(4):349 e1-7.
54. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens ND. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem. 2003;36(8):647-55.
55. Cole LA. Human chorionic gonadotropin (hCG) and hyperglycosylated hCG: the mediators that control human pregnancy. Expert Rev Obstet Gynecol. 2011;6(3):273-83.
56. Madsen BW. Spare receptors. Clin Exp Pharmacol Physiol. 1979;6(6):713-4.
57. Marunaka Y, Niisato N, Miyazaki H. New concept of spare receptors and effectors. J Membr Biol. 2005;203(1):31-9.
58. Siebers JW, Wuttke W, Engel W. HCG-binding capacity of the rat ovary during pregnancy. Acta Endocrinol (Copenh). 1977;86(1):173-9.
59. Han SW, Lei ZM, Rao CV. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol Reprod. 1997;57(1):158-64.
60. Rao CV, Sanfilippo J. New understanding in the biochemistry of implantation: Potential direct roles of luteinizing hormone and human chorionic gonadotropin. The Endocrinologist. 1997;7(2):107.
61. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E, et al. Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J Clin Endocrinol Metab. 2004;89(2):952-6.
62. Akoum A, Metz CN, Morin M. Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone. J Clin Endocrinol Metab. 2005;90(5):2904-10.
63. Azuma K, Calderon I, Besanko M, MacLachlan V, Healy DL. Is the luteo-placental shift a myth? Analysis of low progesterone levels in successful art pregnancies. J Clin Endocrinol Metab. 1993;77(1):195-8.
64. Berndt S, Blacher S, Perrier d'Hauterive S, Thiry M, Tsampalas M, Cruz A, et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J Clin Endocrinol Metab. 2009;94(11):4567-74.
65. Cole LA. hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. J Reprod Immunol. 2009;82(2):112-8.
66. Doheny HC, Houlihan DD, Ravikumar N, Smith TJ, Morrison JJ. Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel. J Clin Endocrinol Metab. 2003;88(9):4310-5.
67. Duncan WC, Rodger FE, Illingworth PJ. The human corpus luteum: reduction in macrophages during simulated maternal recognition of pregnancy. Hum Reprod. 1998;13(9):2435-42.
68. Eblen A, Bao S, Lei ZM, Nakajima ST, Rao CV. The presence of functional luteinizing hormone/chorionic gonadotropin receptors in human sperm. J Clin Endocrinol Metab. 2001;86(6):2643-8.
69. Edelstam G, Karlsson C, Westgren M, Lowbeer C, Swahn ML. Human chorionic gonadatropin (hCG) during third trimester pregnancy. Scand J Clin Lab Invest. 2007;67(5):519-25.
70. Eta E, Ambrus G, Rao CV. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol Metab. 1994;79(6):1582-6.
71. Gawronska B, Paukku T, Huhtaniemi I, Wasowicz G, Ziecik AJ. Oestrogen-dependent expression of LH/hCG receptors in pig Fallopian tube and their role in relaxation of the oviduct. J Reprod Fertil. 1999;115(2):293-301.
72. Goldsmith PC, McGregor WG, Raymoure WJ, Kuhn RW, Jaffe RB. Cellular localization of chorionic gonadotropin in human fetal kidney and liver. J Clin Endocrinol Metab. 1983;57(3):654-61.
73. Hamada AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, et al. Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab. 2005;90(8):4873-9.
74. Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT, et al. HCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta. 2007;28 Suppl A:S85-93.
75. Hirose T. Exogenous stimulation of corpus luteum formation in the rabbit: influence of extracts of human placenta, decidua, fetus, hydatid mole, and corpus luteum on the rabbit gonad. J Jpn Gynecol Soc. 1920;16:1055.
76. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 1993;132(5):2262-70.
77. Matsuura T, Sugimura M, Iwaki T, Ohashi R, Kanayama N, Nishihira J. Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice. J Assist Reprod Genet. 2002;19(12):591-5.
78. Mayerhofer A, Fritz S, Grunert R, Sanders SL, Duffy DM, Ojeda SR, et al. D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin. J Clin Endocrinol Metab. 2000;85(12):4750-7.
79. Rao CV. Chapter 11: Paradigm shift on the targets of hCG actions. In: Human chorionic gonadotropin (hCG) ed. Cole LA E, Oxford UK, editor.; 2010.
80. Perrier d'Hauterive S, Berndt S, Tsampalas M, Charlet-Renard C, Dubois M, Bourgain C, et al. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest. 2007;64(3):156-60.
81. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465-95.
82. Rao CV. Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol (Copenh). 1979;90(4):696-710.
83. Rao CV. Immunocytochemical localization of gonadotropin and gonadal steroid receptors in human pineal glands. J Clin Endocrinol Metab. 1997;82(8):2756-7.
84. Rao CV. The role of human chorionic gonadotropin and cAMP/protein kinase A signaling in the differentiation of human endometrial stromal cells. J Clin Endocrinol Metab. 2001;86(8):4000-1.
85. Rao CV. Physiological and pathological relevance of human uterine LH/hCG receptors. J Soc Gynecol Investig. 2006;13(2):77-8.
86. Rao CV, Griffin LP, Carman FR, Jr. Prostaglandin F2alpha binding sites in human corpora lutea. J Clin Endocrinol Metab. 1977;44(6):1032-7.
87. Rao CV, Li X, Toth P, Lei ZM. Expression of epidermal growth factor, transforming growth factor-alpha, and their common receptor genes in human umbilical cords. J Clin Endocrinol Metab. 1995;80(3):1012-20.
88. Rao CV, Li X, Toth P, Lei ZM, Cook VD. Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol Metab. 1993;77(6):1706-14.
89. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70(2):421-30.
90. Shi QJ, Lei ZM, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology. 1993;132(3):1387-95.
91. Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab. 1969;29(9):1157-67.
92. Toth P, Li X, Rao CV, Lincoln SR, Sanfilippo JS, Spinnato JA, 2nd, et al. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab. 1994;79(1):307-15.
93. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, et al. Clinical importance of vascular LH/hCG receptors-a review. Reprod Biol. 2001;1(2):5-11.
94. Wasowicz G, Derecka K, Stepien A, Pelliniemi L, Doboszynska T, Gawronska B, et al. Evidence for the presence of luteinizing hormone-chorionic gonadotrophin receptors in the pig umbilical cord. J Reprod Fertil. 1999;117(1):1-9.
95. Yeko TR, Khan-Dawood FS, Dawood MY. Human corpus luteum: luteinizing hormone and chorionic gonadotropin receptors during the menstrual cycle. J Clin Endocrinol Metab. 1989;68(3):529-34.
96. Zuo J, Lei ZM, Rao CV. Human myometrial chorionic gonadotropin/luteinizing hormone receptors in preterm and term deliveries. J Clin Endocrinol Metab. 1994;79(3):907-11.
97. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002;87(11):5290-6.
98. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;110 Suppl 1:S10-8.
99. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6(7):1899-904.
100. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, et al. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol. 1989;109(2):891-902.
101. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol. 1999;30(1):48-60.
102. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M. TGF-betainduced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol. 2005;203(2):345-52.
103. Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol. 2005;3:56.
104. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem. 1990;265(23):13933-8.
105. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the Survival of Early Pregnancy. New Engl J Med. 2001;345(19):1400-8.
106. Semprini AE, Simoni G. Not so inefficient reproduction. Lancet. 2000;356(9225):257-8.
107. Cole LA. Pregnancy failure. J Reprod Immunol. 2012:[Epub A head of Print].
108. Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. Clin Chem. 1999;45(12):2109-19.
109. Weinans MJ, Butler SA, Mantingh A, Cole LA. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities. Prenat Diagn. 2000;20(12):976-8.
110. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn. 2002;22(6):478-81.
111. Goldman-Wohl D, Yagel S. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol. 2002;187(1-2):233-8.
112. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4.
113. Cunnane SC, Harbige LS, Crawford MA. The importance of energy and nutrient supply in human brain evolution. Nutr Health. 1993;9(3):219.
114. Gibbons A. Solving the brain's energy crisis. Science. 1998;280(5368):1345-7.
115. Martin RD. Scaling of the mammalian barrier: the maternal energy hypothesis. News Physiol Sci. 1996;4:149-54.
116. Cole LA. Evolution of hCG, evolution of humans and evolution of human pregnancy disorders and cancer. In: Cole LA (ed), Human chorionic gonadotropin (hCG). Elsevier, Burlington MA. 2010:361-276.
117. Maston GA, Ruvolo M. Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. Mol Biol Evol. 2002;19(3):320-35.
118. Bambra CS. Purification and properties of baboon chorionic go nadotrophin. J Reprod Fertil. 1987;79(2):421-30.
119. Crawford RJ, Tregear GW, Niall HD. The nucleotide sequences of baboon chorionic gonadotropin beta-subunit genes have diverged from the human. Gene. 1986;46(2-3):161-9.
120. Cassels JW, Jr., Mann K, Blithe DL, Nisula BC, Wehmann RE. Reduced metabolic clearance of acidic variants of human choriogonadotropin from patients with testicular cancer. Cancer. 1989;64(11):2313-8.
121. Rosa C, Amr S, Birken S, Wehmann R, Nisula B. Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans. J Clin Endocrinol Metab. 1984;59(6):1215-9.
122. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. J Clin Endocrinol Metab. 2006;12(6):747-55.
123. Kliman HJ. Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. Am J Pathol. 2000;157(6):1759-68.
124. Martin RD. Relative brain size and basal metabolic rate in terrestrial vertebrates. Nature. 1981;293(5827):57-60.
125. Martin RD. Human reproduction: a comparative background for medical hypotheses. J Reprod Immunol. 2003;59(2):111-35.
126. Robillard PY, Hulsey TC, Dekker GA, Chaouat G. Preeclampsia and human reproduction. An essay of a long term reflection. J Reprod Immunol. 2003;59(2):93-100.
127. Luckett WP. Comparative development and evolution of the placenta in primates. Contrib Primatol. 1974;3:142-234.
128. Odell WD, Griffin J. Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle. J Clin Endocrinol Metab. 1989;69(3):528-32.
129. Cole LA, Gutierrez JM. Production of human chorionic gonadotropin during the normal menstrual cycle. J Reprod Med. 2009;54(4):245-50.
130. Cole LA. "Background" human chorionic gonadotropin in healthy, nonpregnant women. Clin Chem. 2005;51(10):1765-6.
131. Cole LA, Laidler LL, Muller CY. USA hCG reference service, 10-year report. Clin Biochem. 2010;43(12):1013-22.
132. Snyder JA, Haymond S, Parvin CA, Gronowski AM, Grenache DG. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem. 2005;51(10):1830-5.
133. Gronowski AM, Fantz CR, Parvin CA, Sokoll LJ, Wiley CL, Wener MH, et al. Use of serum FSH to identify perimenopausal women with pituitary hCG. Clin Chem. 2008;54(4):652-6.
134. Laub M, Jennissen HP. Identification of the anthelix motif in the TGF- superfamily by molecular 3D-Rapid Prototyping. Materialwissenschaft und Werkstofftechnik. 2003;34(12):1113-9.
135. Lehnert SA, Akhurst RJ. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development. 1988;104(2):263-73.
136. Acevedo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer. 1995;76(8):1467-75.
137. Bellet D, Lazar V, Bieche I, Paradis V, Giovangrandi Y, Paterlini P, et al. Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res. 1997;57(3):516-23.
138. Bepler G, Jaques G, Oie HK, Gazdar AF. Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. Cancer Lett. 1991;58(1-2):145-50.
139. Butler SA, Iles RK. Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection? Clin Cancer Res. 2003;9(13):4666-73.
140. Butler SA, Iles RK. Biological function of the free β -subunit: expression and treatment target in cancer. Elsevier, Burlington MA. 2010:153-71.
141. Cole LA, Birken S, Sutphen S, Hussa RO, Pattillo RA. Absence of the COOH-terminal peptide on ectopic human chorionic gonadotropin beta-subunit (hCG beta). Endocrinology. 1982;110(6):2198-200.
142. Cole LA, Schwartz PE, Wang YX. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers. Gynecol Oncol. 1988;31(1):82-90.
143. Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, et al. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report. Gynecol Oncol. 1996;60(2):264-70.
144. Cook A, Huddart R, Jay G, Norman A, Dearnaley D, Horwich A. The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer. Br j cancer. 2000;82(12):1952.
145. Cosgrove DE, Campain JA, Cox GS. Chorionic gonadotropin synthesis by human tumor cell lines: examination of subunit accumulation, steady-state levels of mRNA, and gene structure. Biochim Biophys Acta. 1989;1007(1):44-54.
146. Gillott D, Iles RK, Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer. 1996;73(3):323.
147. Iles R. Human chorionic gonadotrophin and its fragments as markers of prognosis in bladder cancer. Tum Mark Upd. 1995;7:161-6.
148. Iles RK. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol. 2007;260-262:264-70.
149. Kinugasa M, Nishimura R, Koizumi T, Morisue K, Higashida T, Natazuka T, et al. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers. Jpn J Cancer Res. 1995;86(8):783-9.
150. Marcillac I, Cottu P, Theodore C, Terrier-Lacombe MJ, Bellet D, Droz JP. Free hCG-beta subunit as tumour marker in urothelial cancer. Lancet. 1993;341(8856):1354-5.
151. Muller CY, Cole LA. The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol Oncol. 2009;112(3):663-72.
152. Nishimura R, Baba S, Hasegawa K, Kinugasa M, Okamura M, Kimura A, et al. [Characterization of immunoreactive hCG betasubunit in cultured fluids of the cell lines derived from gynecologic malignant tumors]. Nihon Sanka Fujinka Gakkai Zasshi. 1990;42(11):1471-6.
153. Carter WB, Sekharem M, Coppola D. Human chorionic gonadotropin induces apoptosis in breast cancer. Breast Cancer Res Treatm. 2006;100:S243-S4.
154. Schwartz PE, Chambers JT, Taylor KJ, Cole LA, Makuch R. Urinary gonadotropin fragments. Anticancer Res. 1993;13:1722-5.
155. Ozturk M, Bellet D, Isselbacher KJ, Wands J. Ectopic beta-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): isolation and immunochemical characterization. Endocrinology. 1987;120(2):559-66.
156. Regelson W. Have we found the "definitive cancer biomarker" ? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy. Cancer. 1995;76(8):1299-301.
157. Rosen SW, Calvert I, Weintraub BD, Tseng JS, Rabson AS. Stimulation of N6, O2'-dibutyryl cyclic adenosine 3':5'-monophosphate of ectopic production of the free beta subunit of chorionic gonadotropin by a human brain tumor cell line. Cancer Res. 1980;40(11):4325-8.
158. Ruddon RW, Norton SE. Use of biological markers in the diagnosis of cancers of unknown primary tumor. Semin Oncol. 1993;20(3):251-60.
159. Szturmowicz M, Slodkowska J, Zych J, Rudzinski P, Sakowicz A, Rowinska-Zakrzewska E. Frequency and clinical significance of betasubunit human chorionic gonadotropin expression in non-small cell lung cancer patients. Tumour Biol. 1999;20(2):99-104.
160. Udagawa Y, Nozawa S, Tsukazaki K, Ohta H, Akiba T, Kurihara S. [Biological properties of two newly established cell lines (SKG-3a,3b) from a human uterine cervical epidermoid carcinoma]. Nihon Sanka Fujinka Gakkai Zasshi. 1984;36(2):237-46.
161. Cole LA, Muller CY. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecol Oncol. 2010;116(1):3-9.
162. Khanlian SA, Smith HO, Cole LA. Persistent low levels of human chorionic gonadotropin: A premalignant gestational tropho blastic disease. Am J Obstet Gynecol. 2003;188(5):1254-9.
163. Acevedo HF, Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ, Hartsock RJ. Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells. Cancer. 1992;69(7):1818-28.
164. Delves PJ, Iles RK, Roitt IM, Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol. 2007;260-262:276-81.
165. He LZ, Ramakrishna V, Connolly JE, Wang XT, Smith PA, Jones CL, et al. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta. Clin Cancer Res. 2004;10(6):1920-7.
166. Iversen PL, Mourich DV, Moulton HM. Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer. Curr Opin Mol Ther. 2003;5(2):156-60.
167. Morse MA, Chapman R, Powderly J, Blackwell K, Keler T, Green J, et al. Phase I study utilizing a novel antigen-presenting celltargeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin Cancer Res. 2011;17(14):4844-53.
168. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res. 2002;8(7):2044-51.
169. Triozzi PL, Stevens VC. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep. 1999;6(1):7-17.